Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03572374 · ClinicalTrials.gov registry record · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
A NA study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 546
- Enrollment target
- 9
- Study locations
NCT03572374: Recruiting NA study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03572374 is a NA study of Breast Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 546 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (81% lower). The trial reports 9 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03572374, a NA study of Breast Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer patients keep their jobs during and after treatment. The app provides advice for patients to use when having conversations about breast cancer with their employers and their doctors. The app is called TEAMWork (Talking to Employers And Medical staff about Work). In this study, the investigators are asking breast cancer patients who are about to receive treatment or who are currently receiving treatment to tell us what aspects of the app work well, so that they can learn how to improve it.
Conditions Studied
Interventions
- OTHER TEAMWork App
- OTHER Information Booklet
Study Locations (9)
New York
- Memorial Sloan Kettering Westchester (Consent and Follow-up) - Harrison
- Queens Cancer Center of Queens Hospital - Jamaica
- Bellevue Hospital Center (Data Collection Only) - New York
- Memorial Sloan Kettering Cancer Center - New York
- Lincoln Medical and Mental Health Center - The Bronx
- Montefiore Medical Center - The Bronx
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-up) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and Follow-up) - Middletown
- Memorial Sloan Kettering Bergen (Consent and Follow up) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2018-06-07 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03572374
The ClinicalTrials.gov registry entry for NCT03572374 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (81% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which TEAMWork App is the first listed.
NCT03572374 reports 9 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03572374 about?
NCT03572374 is a clinical study titled "Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job". The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer patients keep their jobs during and after treatment. The app provides advice for patients to use whe...
What is the current status of trial NCT03572374?
This trial is currently recruiting. It is a NA study. The enrollment target is 546 participants. The study started on 2018-06-07. Estimated completion is 2026-06.
What conditions does trial NCT03572374 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT03572374?
The interventions under investigation include: TEAMWork App (OTHER), Information Booklet (OTHER).
Who is sponsoring clinical trial NCT03572374?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03572374 being conducted?
This trial has 9 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.